|
|
Volumn 52, Issue 4, 1996, Pages 606-623
|
|
Irinotecan: A review of its pharmacological properties and clinical efficacy in the management of advanced colorectal cancer
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
7 ETHYL 10 HYDROXYCAMPTOTHECIN;
ANTINEOPLASTIC AGENT;
CAMPTOTHECIN;
CARBOXYLESTERASE;
DNA TOPOISOMERASE;
DRUG METABOLITE;
ETOPOSIDE;
FLUOROURACIL;
IRINOTECAN;
ALOPECIA;
ANTINEOPLASTIC ACTIVITY;
AREA UNDER THE CURVE;
ASTHENIA;
BONE MARROW SUPPRESSION;
CANCER INHIBITION;
CHOLINERGIC SYSTEM;
CLINICAL TRIAL;
COLORECTAL CANCER;
DIARRHEA;
DRUG BLOOD LEVEL;
DRUG CLEARANCE;
DRUG CONTRAINDICATION;
DRUG DISTRIBUTION;
DRUG ELIMINATION;
DRUG HYDROLYSIS;
DRUG MECHANISM;
DRUG METABOLISM;
DRUG POTENCY;
DRUG STRUCTURE;
DRUG TOLERABILITY;
ENZYME ACTIVITY;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
LEUKOPENIA;
MAJOR CLINICAL STUDY;
META ANALYSIS;
MULTIDRUG RESISTANCE;
NEUTROPENIA;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
REVIEW;
VOMITING;
|
|
EID: 0029841505
PISSN: 00126667
EISSN: None
Source Type: Journal
DOI: 10.2165/00003495-199652040-00013 Document Type: Review |
|
Times cited : (110)
|
|
References (0)
|
